Ocular Therapeutix, Inc. (OCUL) Profit Margins
Over the twelve months to 2026-06-30, Ocular Therapeutix, Inc. (OCUL) had gross margin 87.1%, operating margin -603.0%, net margin -579.1%, free cash flow margin -490.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OCULOcular Therapeutix, Inc.Follow OCUL — free
—
Price chart with a free account
- Market cap
- 1.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 88.2% | 81.8% | 76.5% | 76.2% | — | 45.0% | 88.0% | 89.9% | 91.2% | 91.0% | 91.2% | 87.3% | 87.1% | |
| Operating margin | -3509.6% | -2182.7% | -2296.0% | -3220.1% | -2970.8% | -2029.9% | -361.1% | -179.3% | -152.7% | -141.0% | -269.6% | -519.8% | -603.0% | |
| Net margin | -3710.9% | -2271.3% | -2369.0% | -3296.2% | -3014.0% | -2043.3% | -894.3% | -15.1% | -138.0% | -138.1% | -303.7% | -511.9% | -579.1% | |
| FCF margin | -2818.1% | -2029.8% | -1903.6% | -3053.8% | -2568.6% | -1888.2% | -312.6% | -153.4% | -123.0% | -130.6% | -213.4% | -417.5% | -490.1% |
USD millions · SEC XBRL
Ocular Therapeutix, Inc. — questions
- What is Ocular Therapeutix, Inc.'s gross margin?
- 87.1% over the twelve months to 2026-06-30.
- What is Ocular Therapeutix, Inc.'s operating margin?
- -603.0% over the twelve months to 2026-06-30.
- What is Ocular Therapeutix, Inc.'s net profit margin?
- -579.1% over the twelve months to 2026-06-30.
Every figure on this page comes from Ocular Therapeutix, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.